Drugs in clinical development for the treatment of amyotrophic lateral sclerosis.

@article{Martinez2017DrugsIC,
  title={Drugs in clinical development for the treatment of amyotrophic lateral sclerosis.},
  author={Ana Martinez and Maria Del Valle Palomo Ruiz and Daniel I Perez and Carmen Gil},
  journal={Expert opinion on investigational drugs},
  year={2017},
  volume={26 4},
  pages={403-414}
}
INTRODUCTION Amyotrophic Lateral Sclerosis (ALS) is a fatal motor neuron progressive disorder for which no treatment exists to date. However, there are other investigational drugs and therapies currently under clinical development may offer hope in the near future. Areas covered: We have reviewed all the ALS ongoing clinical trials (until November 2016) and collected in Clinicaltrials.gov or EudraCT. We have described them in a comprehensive way and have grouped them in the following sections… CONTINUE READING